It is the twentieth anniversary of the new patent act in January 2025. The post-patent (P20) era is a story of resilience, determination, and charting a course that set global ambitions, a story of finding opportunity in adversity. It is a story for case studies in business schools, in international studies, in global health efforts.

A Digital-in-pharma special issue. Announcement for ACG-MedicinMan's "Pharmaceutical Marketing in the New Age" conference to be held in March 2018

Articles by Vivek Hattangadi, Raja Reddy, K. Hariram, Satish Kota, P. S. Parameswaran, Gopal Kishore, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal and Mahendra Kumar Rai

Is Pharma’s business model like McDonald’s? Doing things over & over again without innovation? McDonald’s is famous for its Hamburger University, a training facility at the McDonald’s Corporation global headquarters in Chicago, Illinois. It instructs high-potential restaurant managers in restaurant management. More than 5,000 students attend Hamburger University each year and over 275,000 people have graduated with a degree in Hamburgerology. Sound familiar? Pharma’s training has been on similar lines – hire people continuously and put them through the grind of mugging up essentials of drugs for diseases that the particular company sells. While the McDonald’s model is ideal for its business of replication, it has outlived its utility in healthcare and drug companies are in danger of being reduced to mere suppliers of drugs to new digital platform businesses unless they learn to innovate.

In our rapidly changing world, adaptability is essential. The strategies and decisions that yielded results yesterday might not be as effective today. By actively engaging with and updating our mental models, we position ourselves to adapt swiftly to evolving circumstances. This ensures our decisions remain timely and anchored in the present.

In September 2011, MedicinMan published a UCPMP Special Issue...

When Regeneron Pharmaceuticals and Bayer AG signed a licensing...

Indian pharmaceuticals have long been known as the “pharmacy...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

In September 2011, MedicinMan published a UCPMP Special Issue...

When Regeneron Pharmaceuticals and Bayer AG signed a licensing...

Indian pharmaceuticals have long been known as the “pharmacy...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

In September 2011, MedicinMan published a UCPMP Special Issue...

When Regeneron Pharmaceuticals and Bayer AG signed a licensing...

Indian pharmaceuticals have long been known as the “pharmacy...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

In September 2011, MedicinMan published a UCPMP Special Issue...

When Regeneron Pharmaceuticals and Bayer AG signed a licensing...

Indian pharmaceuticals have long been known as the “pharmacy...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...